Won S. Eum
Chuncheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
RETRACTED: Choi et al. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease. Molecules 2021, 26, 3329.
Journal: Molecules (Basel, Switzerland)
Published: July 07, 2026
Tat-GSTpi suppresses inflammatory responses by regulating ROS/MAPKs/apoptosis signaling pathways.
Journal: BMB reports
Published: June 11, 2025
Tat-CIAPIN1 Prevents Pancreatic β-Cell Death in hIAPP-Induced RINm5F Cells and T2DM Animal Model.
Journal: International journal of molecular sciences
Published: May 25, 2023
Tat-RAN attenuates brain ischemic injury in hippocampal HT-22 cells and ischemia animal model.
Journal: Neurochemistry international
Published: February 16, 2023
Tat-GSTpi Inhibits Dopaminergic Cells against MPP+-Induced Cellular Damage via the Reduction of Oxidative Stress and MAPK Activation.
Journal: Biomedicines
Published: February 15, 2023
Protective Effects of PEP-1-GSTA2 Protein in Hippocampal Neuronal Cell Damage Induced by Oxidative Stress.
Journal: International journal of molecular sciences
Published: December 21, 2022
RETRACTED: PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.
Journal: Molecules (Basel, Switzerland)
Published: May 12, 2021
Last Updated: 09/26/2026